Invenomic Capital Management’s Crane NXT CXT Stock Holding History

Invenomic Capital Management’s Portfolio CXT Stock Details CXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12M	Buy	233,914 +85,733	+58%	+$3.66M	0.71%	49
2026 Q1	$6.01M	Sell	148,181 -6,120	-4%	-$297K	0.28%	92
2025 Q4	$7.26M	Buy	+154,301	New	+$9.12M	0.34%	91
2025 Q3	–	Sell	-128,889	Closed	-$6.95M	–	150
2025 Q2	$6.95M	Buy	128,889 +3,262	+3%	+$166K	0.39%	79
2025 Q1	$6.46M	Sell	125,627 -14,261	-10%	-$836K	0.33%	95
2024 Q4	$8.14M	Buy	+139,888	New	+$8.03M	0.39%	87
2021 Q2	–	Sell	-25,151	Closed	-$821K	–	131
2021 Q1	$821K	Sell	25,151 -18,561	-42%	-$550K	0.18%	91
2020 Q4	$1.18M	Buy	+43,712	New	+$963K	0.3%	67

Other funds holding CXT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return

Invenomic Capital Management's CXT Position: Q2 2026 in Review

Invenomic Capital Management increased its Crane NXT (CXT) stake by 58% in Q2 2026, buying an estimated $3.66M and bringing the position to 233,914 shares worth $12M. The position accounts for 0.71% of the portfolio, ranked #49.

Invenomic Capital Management first reported a position in CXT in Q4 2020 and has held it in 8 quarters since. 354 funds tracked by Wall St. Rank hold CXT as of Q2 2026.

Invenomic Capital Management held 233,914 shares of Crane NXT worth $12M as of Q2 2026.
Invenomic Capital Management bought 85,733 Crane NXT shares in Q2 2026, an estimated $3.66M.
Crane NXT made up 0.71% of Invenomic Capital Management's portfolio in Q2 2026, its #49 holding.
Invenomic Capital Management first reported a position in Crane NXT in Q4 2020 and has held it in 8 quarters since.
354 funds tracked by Wall St. Rank held Crane NXT as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.